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Background: The risk of sudden cardiac death (SCD) after NSTEMI in the current therapeutic era is poorly characterized.
methods: The TRACER trial randomized 12,944 NSTE ACS patients to vorapaxar or placebo; 12,857 had MI at presentation. Independently 
adjudicated SCD was defined as witnessed, occurring < 60 min after new symptoms; or unwitnessed ≤24 h of observed alive, no prior progressive 
circulatory failure. Among those discharged alive, we sought to describe SCD incidence and to identify independent predictors of SCD using Fine-Grey 
and Cox models.
results: Patients with SCD were older (median 71 y [IQR, 61-78]) vs those without (64 y, [58-71]), more frequently had ejection fraction (LVEF) 
<35% (19.6% vs 5.4%), diabetes (54.7% vs 31.2%), prior MI (47.2% vs 28.9%), PAD (19.3% vs 7.1%), and worse renal function. At a median follow-
up of 1.4 y (1.0-1.8), 138 of 302 (45.7%) cardiovascular deaths (CVD) were sudden (Figure). SCD was not different between vorapaxar vs. placebo 
but was independently associated with age > 75 y (HR 1.7, 95% CI 1.2-2.2 per 5 y), LVEF < 35% (HR 3.5 [ 2.0-6.1]), PAD (HR 2.3 [1.5-3.6]), 
diabetes (HR 2.1 [1.4-3.0]), CrCl <80 (HR 0.8 [0.7-0.9] per 10 U), and prior PCI (HR 0.6 [0.3-1.0]).
conclusions: SCD after NSTEMI hospitalization is infrequent but comprises nearly half of CVD. Risk factors for SCD largely overlap with known 
predictors of recurrent coronary events, suggesting common etiology. Future studies should focus on defining primary prevention strategies in high-
risk patients.
